Administration methods of lipid-based nanoparticle delivery systems for cancer treatment
Biomaterials Science · 2023
DOI: 10.1039/d3bm00219e ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Science, 2023. Verfasst von Yixuan Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Oral Health Research, Hunan 3D Printing Engineering Research Center of Oral Care, Hunan Clinical Research Center of Oral Majo…. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Key Research and Development Program of Hunan Province of China, Central South University, National Natural Science Foundation of China.
Abstract (Originalsprache)
This article focuses on the different administration methods of lipid-based nanoparticles in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hunan Key Laboratory of Oral Health Research, Hunan 3D Printing Engineering Research Center of Oral Care, Hunan Clinical Research Center of Oral Major Diseases and Oral Health, Xiangya Stomatological Hospital, Xiangya S…
Förderung
- Key Research and Development Program of Hunan Province of China
- Central South University
- National Natural Science Foundation of China
- Health Commission of Hunan Province
Zitieren
APA
Lu, Y., Pan, X., Nie, Q., Zhou, Z., Dai, X., & Liu, O. (2023). Administration methods of lipid-based nanoparticle delivery systems for cancer treatment. Biomaterials Science. https://doi.org/10.1039/d3bm00219e
Vancouver
Lu Y, Pan X, Nie Q, Zhou Z, Dai X, Liu O. Administration methods of lipid-based nanoparticle delivery systems for cancer treatment. Biomaterials Science. 2023. doi:10.1039/d3bm00219e
BibTeX
@article{Lu2023,
author = {Lu, Yixuan and Pan, Xiaoman and Nie, Qian and Zhou, Zekun and Dai, Xiaohan and Liu, Ousheng},
title = {Administration methods of lipid-based nanoparticle delivery systems for cancer treatment},
journal = {Biomaterials Science},
year = {2023},
doi = {10.1039/d3bm00219e}
}
EUVIMED